Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Rocket Pharmaceuticals, Inc.

NASDAQ: RCKT · Life Sciences · 6 alerts · CIK 1281895

Share price
$2.16Close, Nov 16
Market cap
$241M
Shares outstanding
111.66MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Rocket Pharmaceuticals, Inc. filings on SEC EDGAR ↗

6:44 PM ET Form 4
Insider Selling

Rocket Pharmaceuticals Insider Sarbani Chaudhuri Sells $11.3K of Stock

Sarbani Chaudhuri sold 4,872 shares of Rocket Pharmaceuticals, Inc. at $2.33 a share, worth $11.3K in total on Nov 9, 2026. Shares held after the trade: 257,937 (-1.9%).

Value
$11.3K
Shares
4,872
Price
$2.33
Holding change
-1.9%
Trade date
Nov 9, 2026
4:16 PM ET 8-K
Financial Results

Rocket Pharmaceuticals Financial Results

Rocket Pharmaceuticals reported third quarter 2026 financial results, highlighting FDA alignment on the pivotal Phase 2 trial for RP-A501 in Danon disease with dosing completion expected by mid-2027. The company ended the quarter with $279.4 million in cash and investments, which is expected to fund operations into the third quarter of 2028.

Term
Q3 2026

“With FDA alignment on the pivotal RP-A501 trial in Danon disease, our priority is to complete dosing by mid-2027. We are also advancing our broader cardiovascular portfolio, with dosing initiated in the Phase 1 trial of RP-A701 for BAG3-DCM and continued FDA engagement on a potential pivotal study of RP-A601 in PKP2-ACM. Commercial readiness for KRESLADI and activation of our first Qualified Treatment Centers bring us closer to treating eligible children. Our financial resources and the additional flexibility provided by the Hercules facility support these priorities as we work toward our next clinical and commercial milestones.”

Gaurav Shah, M.D., Chief Executive Officer of Rocket Pharmaceuticals

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.